Srikanth Pendyala, MD

Consultant of Clinical Research in Immune and Inflammatory Diseases

Dr. Pendyala has 25 years of I&I experience in both academia and the industry (both large pharma and small biotech). He has spent his career working at the intersection of clinical care and research. In supporting Rezubio, Dr. Pendyala brings that perspective into the design and oversight of clinical studies. His approach emphasizes thoughtful trial design, clear standards of care, and accountability throughout the research and development process. With multiple drug approvals in respiratory and a number of INDs filed over the years, he brings both the clinical and regulatory strategy to the forefront of clinical development.